Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors.

× No keyword cloud information.

12 in total

Review 1. Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder.

Authors: Michael G Oefelein
Journal: Drug Saf Date: 2011-09-01 Impact factor: 5.606

2. Anticholinergics and central nervous system effects: are we confused?

Authors: David R Staskin; Edward Zoltan
Journal: Rev Urol Date: 2007

3. Concurrent use of anticholinergic drugs and cholinesterase inhibitors: register-based study of over 700,000 elderly patients.

Authors: Kristina Johnell; Johan Fastbom
Journal: Drugs Aging Date: 2008 Impact factor: 3.923

Review 4. Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients.

Authors: Dustin Pagoria; R Corey O'Connor; Michael L Guralnick
Journal: Curr Urol Rep Date: 2011-10 Impact factor: 3.092

5. Prevalence and determinants of anticholinergic medication use in elderly dementia patients.

Authors: Sneha D Sura; Ryan M Carnahan; Hua Chen; Rajender R Aparasu
Journal: Drugs Aging Date: 2013-10 Impact factor: 3.923

Review 6. Brain Over Bladder: A Systematic Review of Dual Cholinesterase Inhibitor and Urinary Anticholinergic Use.

Authors: Laura K Triantafylidis; Jenna S Clemons; Emily P Peron; John Roefaro; Kristin M Zimmerman
Journal: Drugs Aging Date: 2018-01 Impact factor: 3.923

Review 7. Trospium chloride in the management of overactive bladder.

Authors: Eric S Rovner
Journal: Drugs Date: 2004 Impact factor: 9.546

8. Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes.

Authors: Kaycee M Sink; Joseph Thomas; Huiping Xu; Bruce Craig; Steven Kritchevsky; Laura P Sands
Journal: J Am Geriatr Soc Date: 2008-04-01 Impact factor: 5.562

Review 9. Benefit-risk assessment of tolterodine in the treatment of overactive bladder in adults.

Authors: Alan D Garely; Lara Burrows
Journal: Drug Saf Date: 2004 Impact factor: 5.606

Review 10. Nocturia in Parkinson's Disease: Why Does It Occur and How to Manage?

Authors: Amit Batla; Véronique Phé; Lorenzo De Min; Jalesh N Panicker
Journal: Mov Disord Clin Pract Date: 2016-06-07